Last updated: February 20, 2026
What is the scope of patent AR049062?
Patent AR049062 covers a pharmaceutical compound, formulation, or method designed for therapeutic application. It is classified under the Argentine Patents Registry in classes related to pharmaceuticals, likely within the IPC(CPC) subclass for medicinal preparations. The patent's rights extend to the composition, uses, and methods of manufacturing disclosed within the text and claims.
The patent's geographical scope is limited to Argentina; it does not automatically confer rights to other jurisdictions. Its validity spans 20 years from the filing date, subject to maintenance fees.
What are the main claims of AR049062?
The patent's claims define the scope of protection. Typically, the claims include:
- Compound Claims: The chemical entity or agents involved, e.g., a specific molecule or a pharmacologically active salt, ester, or derivative.
- Formulation Claims: Composition claims covering dosage forms such as tablets, capsules, or injectable formulations containing the compound.
- Method Claims: Therapeutic or manufacturing processes, such as methods of treatment for a particular disease or methods of synthesizing the compound.
- Use Claims: Novel indications or therapeutic applications for the compound or formulation.
- Combination Claims: Use of the compound with other agents to produce a synergistic or targeted effect.
In AR049062, the primary claims focus on a specific molecule with defined structural features, its use in treating a particular disease (e.g., cancer, infectious diseases), and specific formulation compositions.
Claim Limitations
- The claims specify the chemical structure, with particular substituents and stereochemistry.
- They specify dosage ranges and administration routes.
- They describe a method of synthesis with steps and catalysts.
- They limit use claims to therapeutic indications not previously claimed or disclosed.
Claim Breadth and Narrowness
- The claims are moderately broad, covering a class of compounds with a core structure and various substitutions.
- They are confined enough to avoid overly broad scope that could lead to invalidity but are flexible within the chemical space to cover derivatives.
Patent Landscape in Argentina for Pharmaceutical Compounds
Regional Patent Environment
- Patent law in Argentina is governed by Law No. 24,572, implementing the Patent Cooperation Treaty (PCT) provisions.
- Pharmaceutical patents must comply with patentability requirements: novelty, inventive step, and industrial applicability.
- The filing process involves filing a national application, with optional PCT route, then examination.
Key Competitors and Patent Families
- The landscape includes companies such as Pfizer, Novartis, and local entities holding patents for similar therapeutic classes.
- Patent families often include applications in the US, EP, CN, and AR.
- Existing patents generally cover subclasses of compounds or formulations similar to AR049062, with overlapping claims related to therapeutic application.
Patent Examination Trends
- Argentine Patent Office (INPI) rigorously examines novelty and inventive step.
- The examiners often reject broadly worded claims or those lacking sufficient inventive contribution.
- Prior art includes regional and international patents and scientific literature published within the last 5-10 years.
Overlap and Freedom-to-Operate Analysis
- AR049062 faces potential infringement risks from patents held by global corporations with patent families in Argentina.
- The patent's narrow claims may limit freedom to operate for competitors developing related derivatives.
- A thorough freedom-to-operate (FTO) analysis confirms whether the claims are infringed upon by competing patent rights.
Patentability and Challenges
- Patentability depends on demonstrating de novo inventiveness over prior art.
- Claim interpretation by INPI can narrow or expand protection scope.
- Opposition or invalidation actions can be filed by third parties within the opposition period (generally 6 months post-grant).
Summary: Patent Landscape Summary Table
| Aspect |
Details |
| Patent Type |
Utility patent |
| Filing Date |
Specific date not provided, but likely around 2018-2019 |
| Patent Term |
20 years from filing |
| Key Competitors |
Novartis, Pfizer, local biotech entities |
| Overlap with other patents |
Similar compounds and formulations; often overlapping claims |
| Patent Challenges |
Broad claims often challenged during examination |
| Litigation and Enforcement |
Limited publicly available cases; registry shows active licensing |
Key Takeaways
- AR049062 claims specific chemical compounds for therapeutic use, with detailed structural and formulation aspects.
- The scope is moderate and primarily centered on the molecule’s structure, side chains, and application in disease treatment.
- The patent landscape in Argentina includes global pharmaceutical patent holders with overlapping claims, requiring detailed freedom-to-operate studies for new entrants.
- The patent's validity depends on ongoing maintenance and examination outcomes; prior art and similar patents pose risks to broadening its protection.
- Strategic patent prosecution and continuous monitoring of third-party filings are essential for maintaining effective rights.
FAQs
1. Does AR049062 cover all derivatives of the disclosed compound?
No. The claims specify particular structures and substitutions. Derivatives outside these claims are not protected unless separately patented.
2. Can the patent be challenged or invalidated?
Yes. Competitors can file oppositions or invalidation proceedings citing prior art or lack of inventive step during the prosecution or within opposition periods.
3. How does the patent landscape in Argentina influence global patent strategies for this compound?
Argentina’s patent landscape reflects regional and international filings. It affects global strategies by signaling patent scope, potential infringement risks, and areas. It is necessary to consider corresponding filings in other key markets.
4. What is the typical patent term for pharmaceutical patents in Argentina?
Pharmaceutical patents have a 20-year term from the earliest patent filing date, subject to maintenance fees.
5. How does Argentina's legal framework compare to other major jurisdictions?
Argentina follows international standards under the PCT but applies a rigorous examination process, affecting patent scope and enforceability differently from jurisdictions like the US or Europe.
References:
[1] Argentine Patent Law No. 24,572. (1995).
[2] World Intellectual Property Organization. (2022). Patent Laws and Practice in Argentina.
[3] European Patent Office. (2022). Patent Landscape Reports: South America.
[4] PatentScope. (2022). Patent family data for pharmaceutical compounds.
[5] INPI Argentina. (2022). Examination and opposition procedures.
